When serum IGF-1 levels were compared among the different experimental groups, we observed that there was a significant increase (p < 0.05), compared with control, in IGF-1 level ten days after commencement of the ISO treatment that led to myocardial ischemia. Here, IGF1 is linked to myocardial ischemia.